Literature DB >> 16713010

Macro and microvascular complications are determinants of increased infection-related mortality in Brazilian type 2 diabetes mellitus patients.

Claudia R L Cardoso1, Gil F Salles.   

Abstract

OBJECTIVE: To investigate infection-related mortality and its predictors in Brazilian type 2 diabetic patients.
METHODS: It was carried out a long-term prospective study with 471 type 2 diabetic outpatients. Several clinical, laboratory and electrocardiographic variables were recorded at baseline. Predictive factors for infection-related mortality were evaluated by Kaplan-Meyer estimation of survival curves, univariate and multivariate Cox survival analysis. Excess infection-related mortality in this cohort was evaluated by comparing its rate with that of the Rio de Janeiro background population and calculating standardized mortality rates (SMR).
RESULTS: During a median follow up of 57 months (range: 1-86 months), 40 (33.1%) patients died from infection-related causes. After adjusting for age and sex, the infection-related SMR was 6.6 (95% confidence interval [95% CI]: 4.8-9.0). In Cox multivariate analysis the predictors of infection-related mortality were older age (hazard ratio [HR]: 1.91; 95% CI: 1.35-2.70), pre-existing peripheral arterial disease (HR: 3.86; 95% CI: 1.80-8.28) and cerebrovascular disease (HR: 3.28; 95% CI: 1.24-8.70), lower HDL-cholesterol (HR: 2.50; 95% CI: 1.32-4.74) and increased 24h-proteinuria (HR: 1.22; 95% CI: 1.08-1.37). After excluding patients with peripheral and cerebrovascular disease at baseline, neuropathy and coronary heart disease were selected as predictors of mortality, besides older age and proteinuria.
CONCLUSIONS: Brazilian type 2 diabetic patients have a six-fold excess infection-related mortality than the general population. This increased mortality is mainly determined by the presence of micro and macrovascular complications. Multifactorial risk interventions are needed in order to decrease this burden of infection-related mortality.

Entities:  

Mesh:

Year:  2006        PMID: 16713010     DOI: 10.1016/j.diabres.2006.04.008

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  5 in total

1.  Age, Pulse, Urea and Albumin (APUA) Model: A Tool for Predicting in-Hospital Mortality of Community-Acquired Pneumonia Adapted for Patients with Type 2 Diabetes.

Authors:  Chun-Ming Ma; Ning Wang; Quan-Wei Su; Ying Yan; Fu-Zai Yin
Journal:  Diabetes Metab Syndr Obes       Date:  2020-10-09       Impact factor: 3.168

2.  The mortality in infectious inpatients with type 2 diabetes compared with non-diabetic population: Infection in type 2 diabetes.

Authors:  Chun-Ming Ma; Fu-Zai Yin
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

3.  Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study.

Authors:  L Prompers; N Schaper; J Apelqvist; M Edmonds; E Jude; D Mauricio; L Uccioli; V Urbancic; K Bakker; P Holstein; A Jirkovska; A Piaggesi; G Ragnarson-Tennvall; H Reike; M Spraul; K Van Acker; J Van Baal; F Van Merode; I Ferreira; M Huijberts
Journal:  Diabetologia       Date:  2008-02-23       Impact factor: 10.122

4.  Increased risk of 30-day postoperative complications for diabetic patients following open reduction-internal fixation of proximal humerus fractures: an analysis of 1391 patients from the American College of Surgeons National Surgical Quality Improvement Program database.

Authors:  Diana C Patterson; John I Shin; Steven M Andelman; Victor Olujimi; Bradford O Parsons
Journal:  JSES Open Access       Date:  2017-04-19

5.  Temporal trends in rates of infection-related hospitalisations in Hong Kong people with and without diabetes, 2001-2016: a retrospective study.

Authors:  Andrea O Y Luk; Hongjiang Wu; Eric S H Lau; Aimin Yang; Wing-Yee So; Elaine Chow; Alice P S Kong; David S C Hui; Ronald C W Ma; Juliana C N Chan
Journal:  Diabetologia       Date:  2020-09-28       Impact factor: 10.122

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.